Clinical Trials Logo
  1. Home
  2. Other
  3. NCT01709773

Focal Ablation of Cervical Precancer

High-grade Cervical Intraepithelial Neoplasia Clinical Trial

Official title:
Focal Ablation of High-grade Cervical Intraepithelial Neoplasia

Clinical Trial Summary

This is a pilot cohort study of women undergoing focal ablation for high-grade cervical intraepithelial neoplasia (HGCIN). The cohort was recruited from the UCSF Dysplasia Clinics. The standard treatment involves treatment of the entire cervix. Women with HGCIN meeting inclusion criteria were recruited for enrollment into the pilot study of focal treatment. Upon enrollment, they underwent focal ablational treatment rather than standard ablational treatment of the cervix. Follow-up visits were conducted at 2 weeks and 6 months to assess safety, feasibility, and acceptability. The 6-month recurrence rate of HGCIN will be calculated.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01709773
Study type Interventional
Source University of California, San Francisco
Contact
Status Completed
Phase N/A
Start date January 17, 2013
Completion date May 26, 2014
View Details
See also
  Status Clinical Trial Phase
Completed NCT03239223 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection Phase 1
Active, not recruiting NCT01511328 - Randomized Implementation of Primary HPV Testing in the Organized Screening for Cervical Cancer in Stockholm N/A
Completed NCT03697226 - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. Phase 1
Completed NCT02220192 - An Alternative Treatment for Cervical Intraepithelial Neoplasia Using the Focal Loop Electrosurgical Excision Procedure N/A